StockData

Endonovo Therapeutics, Inc. (ENDV) bonds

ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2023, quý kết thúc ngày Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $135.08KP/E –Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2023

Endonovo Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2022

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Endonovo Therapeutics's 10-Q for the period ended Sep 30, 2023

IssueCouponAmount issuedCarrying value
Eight Fixed Promissory Notes15.00%–$950.00K
Eighteen Fixed Rate–$1.47M–
Eighteen Fixed Rated Notes––$1.92M
Fixed Rate Notes––$1.85M
Fixed Rated Notes––$1.84M
Fourteen Fixed Rated Notes–$1.40M–
One Promissory Notes––$465.00K
One Variable Note–$163.83K–
Sixteen Fixed Rated Notes––$1.89M
Three Fixed Rated Notes15.00%––

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?